358 related articles for article (PubMed ID: 22262593)
21. "First-wave" bias when conducting active safety monitoring of newly marketed medications with outcome-indexed self-controlled designs.
Wang SV; Schneeweiss S; Maclure M; Gagne JJ
Am J Epidemiol; 2014 Sep; 180(6):636-44. PubMed ID: 25086050
[TBL] [Abstract][Full Text] [Related]
22. Multiple self-controlled case series for large-scale longitudinal observational databases.
Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
[TBL] [Abstract][Full Text] [Related]
23. A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and evaluation of bias.
Hua W; Sun G; Dodd CN; Romio SA; Whitaker HJ; Izurieta HS; Black S; Sturkenboom MC; Davis RL; Deceuninck G; Andrews NJ
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):819-25. PubMed ID: 23625875
[TBL] [Abstract][Full Text] [Related]
24. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety.
Robb MA; Racoosin JA; Sherman RE; Gross TP; Ball R; Reichman ME; Midthun K; Woodcock J
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():9-11. PubMed ID: 22262587
[No Abstract] [Full Text] [Related]
25. Overlap bias in the case-crossover design, with application to air pollution exposures.
Janes H; Sheppard L; Lumley T
Stat Med; 2005 Jan; 24(2):285-300. PubMed ID: 15546133
[TBL] [Abstract][Full Text] [Related]
26. Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review.
Gault N; Castañeda-Sanabria J; Guillo S; Foulon S; Tubach F
Pharmacoepidemiol Drug Saf; 2016 Apr; 25(4):372-7. PubMed ID: 26781227
[TBL] [Abstract][Full Text] [Related]
27. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
28. A positive event dependence model for self-controlled case series with applications in postmarketing surveillance.
Simpson SE
Biometrics; 2013 Mar; 69(1):128-36. PubMed ID: 23006045
[TBL] [Abstract][Full Text] [Related]
29. Statistical methods for epidemiologic studies of the health effects of air pollution.
Navidi W; Thomas D; Langholz B; Stram D
Res Rep Health Eff Inst; 1999 May; (86):1-50; discussion 51-6. PubMed ID: 10465799
[TBL] [Abstract][Full Text] [Related]
30. Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores.
Eng PM; Seeger JD; Loughlin J; Clifford CR; Mentor S; Walker AM
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):297-305. PubMed ID: 18215000
[TBL] [Abstract][Full Text] [Related]
31. Benzodiazepines and elderly drivers: a comparison of pharmacoepidemiological study designs.
Hebert C; Delaney JA; Hemmelgarn B; Lévesque LE; Suissa S
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):845-9. PubMed ID: 17563091
[TBL] [Abstract][Full Text] [Related]
32. Interpreting the term selection bias in medical research.
Mark DH
Fam Med; 1997 Feb; 29(2):132-6. PubMed ID: 9048175
[TBL] [Abstract][Full Text] [Related]
33. Self-controlled case series and misclassification bias induced by case selection from administrative hospital databases: application to febrile convulsions in pediatric vaccine pharmacoepidemiology.
Quantin C; Benzenine E; Velten M; Huet F; Farrington CP; Tubert-Bitter P
Am J Epidemiol; 2013 Dec; 178(12):1731-9. PubMed ID: 24077093
[TBL] [Abstract][Full Text] [Related]
34. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials.
Corrao G; Botteri E; Bagnardi V; Zambon A; Carobbio A; Falcone C; Leoni O
Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):31-40. PubMed ID: 15390219
[TBL] [Abstract][Full Text] [Related]
35. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
Glasser SP; Salas M; Delzell E
J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697
[TBL] [Abstract][Full Text] [Related]
36. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies.
Rekers H; Norpoth T; Michaels MA
Eur J Contracept Reprod Health Care; 1996; 1(1):21-30. PubMed ID: 9678134
[TBL] [Abstract][Full Text] [Related]
37. Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned.
Carnahan RM; Moores KG
Pharmacoepidemiol Drug Saf; 2012 Jan; 21 Suppl 1():82-9. PubMed ID: 22262596
[TBL] [Abstract][Full Text] [Related]
38. Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs.
Nicholas JM; Grieve AP; Gulliford MC
J Clin Epidemiol; 2012 Apr; 65(4):384-93. PubMed ID: 22197519
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological approaches to safety investigations.
Wood JL; Adams VJ
Vet Microbiol; 2006 Oct; 117(1):66-70. PubMed ID: 16713135
[TBL] [Abstract][Full Text] [Related]
40. Selection bias and confounding in case-crossover analyses of environmental time-series data.
Bateson TF; Schwartz J
Epidemiology; 2001 Nov; 12(6):654-61. PubMed ID: 11679793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
